Alexander Marquez, MD

Prescribe an SGLT2 inhibitor for heart failure in the absence of diabetes?

Publish date: July 20, 2021

An RCT demonstrates that dapagliflozin produces better cardiovascular outcomes than placebo for heart failure patients with and without diabetes.